Treatment of allergic rhinitis

Area of Science:

• Allergy and Immunology
• Respiratory Medicine
• Pharmacology

Background:

• Allergic rhinitis is a prevalent chronic respiratory condition impacting quality of life and exacerbating comorbidities like asthma.
• Effective management is crucial for patient well-being and productivity.

Purpose of the Study:

• To outline current evidence-based treatment guidelines for allergic rhinitis.
• To differentiate therapeutic approaches based on disease severity and patient age.

Main Methods:

• Review of current literature and clinical guidelines for allergic rhinitis management.
• Analysis of treatment efficacy for various pharmacologic and non-pharmacologic interventions.

Main Results:

• Intranasal corticosteroids are the most effective first-line treatment for mild to moderate allergic rhinitis.
• Second-line therapies include antihistamines, decongestants, and leukotriene receptor antagonists for moderate to severe cases unresponsive to initial treatment.
• Immunotherapy is a consideration for patients with inadequate response to standard therapies.

Conclusions:

• Treatment strategies for allergic rhinitis should be individualized based on patient factors and disease severity.
• Intranasal corticosteroids are the cornerstone of therapy, with a stepwise approach for refractory cases.
• Evidence does not support certain environmental interventions or infant feeding modifications for allergic rhinitis prevention or treatment.